ArticleMolecular and clinical oncology2016

Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib.

Minehiko Inomata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.